Our ‘quick’ screen program was developed to enable our biopharmaceutical clients to obtain a preliminary dataset across assay platforms in a cost-effective manner. Our assays and models are designed to address function and mechanism of action with the intent of facilitating the decision making process on which drug candidates to carry forward.
- Cost-effective – “stitch” together a robust dataset across platforms
- Preliminary proof-of-concept (Go/No Go)
- Compliment internal data or results
- Access to versatile assays and model systems across diseases